<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03527576</url>
  </required_header>
  <id_info>
    <org_study_id>CER 2018-00500</org_study_id>
    <nct_id>NCT03527576</nct_id>
  </id_info>
  <brief_title>Block Duration After Spinal Block and iv Dexamethasone.</brief_title>
  <official_title>Block Duration After Spinal Block and iv Dexamethasone: a Randomized Controlled Double-blinded Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eric Albrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been largely demonstrated that iv dexamethasone prolongs the duration of analgesia
      after peripheral nerve block. However, data are missing regarding the duration of analgesia
      after spinal block. The objective of this randomized controlled double-blinded trial is to
      assess whether intravenous dexamethasone administered after a spinal block, before the
      surgery would prolong sensory block characteristics without impacting the motor block
      duration.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of sensory block (minutes)</measure>
    <time_frame>Postoperative day 0</time_frame>
    <description>Time interval between injection of the local anaesthetic and the regression of 2 dermatoma, compared to the highest dermatoma reached</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Highest dermatoma reached (level)</measure>
    <time_frame>Postoperative day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset time between injection and highest dermatoma (minutes)</measure>
    <time_frame>Postoperative day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total duration of the sensory block (minutes)</measure>
    <time_frame>Postoperative day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total duration of the motor block (minutes)</measure>
    <time_frame>Postoperative day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first analgesic request (minutes)</measure>
    <time_frame>Postoperative day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative consumption of morphine (mg)</measure>
    <time_frame>Postoperative days 0, 1 and 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>Postoperative days 0, 1 and 2</time_frame>
    <description>Numeric rating scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of postoperative nausea and vomiting</measure>
    <time_frame>Postoperative day 0, 1 and 2</time_frame>
    <description>YES/NO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of pruritus</measure>
    <time_frame>Postoperative day 0, 1 and 2</time_frame>
    <description>YES/NO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of urinary retention</measure>
    <time_frame>Postoperative day 1 and 2</time_frame>
    <description>YES/NO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction level</measure>
    <time_frame>Postoperative day 2</time_frame>
    <description>Numeric rating scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>up to 14 days</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent pain</measure>
    <time_frame>3 and 6 postoperative months</time_frame>
    <description>YES/NO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score if persistent pain</measure>
    <time_frame>3 and 6 postoperative months</time_frame>
    <description>Numeric rating scale (0-10)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Lower Limb Injury</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous injection of 0.15 mg/kg of dexamethasone before the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intravenous injection of NaCl 0,9% before the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Intravenous injection of 0.15 mg/kg of dexamethasone before the surgery.</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl 0.0308 MEQ/ML Injectable Solution</intervention_name>
    <description>Intravenous injection of NaCl 0.9% before the surgery.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with ASA I-III status ;

          -  Patient scheduled for an osteosynthesis surgy of the lower limb

        Exclusion Criteria:

          -  Polytrauma patient

          -  Pregnancy

          -  Contraindication to spinal anesthesia

          -  Contraindication to dexamethasone administration

          -  Patient with chronic pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eric Albrecht, PD Dr</last_name>
    <phone>+41 79 556 63 41</phone>
    <email>eric.albrecht@chuv.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jonathan Frauenknecht</last_name>
    <phone>+41 78 960 51 86</phone>
    <email>jonfrauen@bluewin.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois and University of Lausanne</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Albrecht, PD Dr</last_name>
      <phone>+41795566341</phone>
      <email>eric.albrecht@chuv.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2018</study_first_submitted>
  <study_first_submitted_qc>May 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2018</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Eric Albrecht</investigator_full_name>
    <investigator_title>Program director of regional anaesthesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Leg Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

